Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The closing price of Acelyrin Inc (NASDAQ: SLRN) was $2.58 for the day, down -5.84% from the previous closing price of $2.74. In other words, the price has decreased by -$5.84 from its previous closing price. On the day, 0.95 million shares were traded. SLRN stock price reached its highest trading level at $2.67 during the session, while it also had its lowest trading level at $2.56.
Ratios:
Our analysis of SLRN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 18.10 and its Current Ratio is at 18.10. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, H.C. Wainwright on August 14, 2024, Downgraded its rating to Neutral and sets its target price to $6 from $18 previously.
On July 08, 2024, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight but kept the price unchanged to $13.
On December 13, 2023, Wells Fargo started tracking the stock assigning a Equal Weight rating and target price of $11.Wells Fargo initiated its Equal Weight rating on December 13, 2023, with a $11 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 17 ’25 when Kim Mina sold 17,986 shares for $2.74 per share. The transaction valued at 49,354 led to the insider holds 671,753 shares of the business.
Murugan Amar sold 3,913 shares of SLRN for $10,737 on Mar 17 ’25. The Chief Legal Officer now owns 121,587 shares after completing the transaction at $2.74 per share. On Mar 17 ’25, another insider, Mpofu Shephard, who serves as the Chief Medical Officer of the company, sold 3,211 shares for $2.74 each. As a result, the insider received 8,811 and left with 121,789 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLRN now has a Market Capitalization of 259831792 and an Enterprise Value of -180744576.
Stock Price History:
The Beta on a monthly basis for SLRN is 1.12, which has changed by -0.5749588 over the last 52 weeks, in comparison to a change of 0.036926866 over the same period for the S&P500. Over the past 52 weeks, SLRN has reached a high of $7.25, while it has fallen to a 52-week low of $1.85. The 50-Day Moving Average of the stock is 8.21%, while the 200-Day Moving Average is calculated to be -37.64%.
Shares Statistics:
SLRN traded an average of 2.23M shares per day over the past three months and 954850 shares per day over the past ten days. A total of 100.45M shares are outstanding, with a floating share count of 73.01M. Insiders hold about 27.51% of the company’s shares, while institutions hold 76.06% stake in the company. Shares short for SLRN as of 1741910400 were 4684387 with a Short Ratio of 2.10, compared to 1739491200 on 4715987. Therefore, it implies a Short% of Shares Outstanding of 4684387 and a Short% of Float of 5.050000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
